Home » Topics » BioWorld Asia

BioWorld Asia
RSS

GAIFAR Financing Raises DM10M To Push HIV Test

Dec. 30, 1998

SR Pharma, Corixa Sign Deal For Mycobacterium Vaccae Drugs

Dec. 30, 1998

FuCell's Hybridoma Cell Method Seeks Customers

Dec. 30, 1998

Viron Studying Proteins' Role In Immune System

Dec. 30, 1998

Investors Failing To See Israeli Agbiotech Potential

Dec. 30, 1998

Xenova Research Program Targets Southern Mexico

Dec. 30, 1998

Australian Report Urges Ban On Human Cloning

Dec. 30, 1998

Mologen, Virbac Enter Agreement For Vaccines

Dec. 23, 1998

Australian Food Industry Assails Labeling Decision

Dec. 23, 1998

British Biotech Drops One Marimastat Study

Dec. 23, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 31, 2025.
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...
IMV-101 shows promise for B-cell malignancies
BioWorld Science
IMV-101 is a new CAR T-cell therapy targeting CD19 developed by Suzhou Immunofoco Biotechnology Co. Ltd. for the potential treatment of B-cell malignancies and...